Aberrant splicing and defective mRNA production induced by somatic spliceosome mutations in myelodysplasia
Mutations to the splicing machinery may have an important role in myelodysplasia. Here, the authors describe splicing factor gene mutations in myelodysplasia and report tumor suppressor, epigenetic, iron metabolism and heme biosynthesis genes as their targets.
Guardado en:
Autores principales: | Yusuke Shiozawa, Luca Malcovati, Anna Gallì, Aiko Sato-Otsubo, Keisuke Kataoka, Yusuke Sato, Yosaku Watatani, Hiromichi Suzuki, Tetsuichi Yoshizato, Kenichi Yoshida, Masashi Sanada, Hideki Makishima, Yuichi Shiraishi, Kenichi Chiba, Eva Hellström-Lindberg, Satoru Miyano, Seishi Ogawa, Mario Cazzola |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d51021625acb4fb6bc05018865814b72 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Invariant patterns of clonal succession determine specific clinical features of myelodysplastic syndromes
por: Yasunobu Nagata, et al.
Publicado: (2019) -
Clonal evolution and clinical implications of genetic abnormalities in blastic transformation of chronic myeloid leukaemia
por: Yotaro Ochi, et al.
Publicado: (2021) -
Hematopoietic stem and progenitor cell-restricted Cdx2 expression induces transformation to myelodysplasia and acute leukemia
por: Therese Vu, et al.
Publicado: (2020) -
Evolution of the Early Spliceosomal Complex—From Constitutive to Regulated Splicing
por: Sonia Borao, et al.
Publicado: (2021) -
Therapeutic activity of modified U1 core spliceosomal particles
por: Malgorzata Ewa Rogalska, et al.
Publicado: (2016)